Biopact’s Technology Can Transport Molecules Into The Cell More Safely And More Effectively Than Any Other Delivery Mechanism. Biopact has developed a breakthrough intracellular delivery vehicle called MGMR. MGMR can transport next-generation cellular medicines more safely, and effectively than anything available today. Its unique composition is a major reason why this is possible. MGMR has an ultra high surface-to-volume ratio that enables it to carry molecules other delivery methods cannot, including gene-editing materials, drugs, and enzymes. MGMR is a universal transport system. Unlike other delivery vehicles, it is not cargo- or treatment-specific. It can effectively deliver a variety of treatments to different cell types. MGMR Is The Ultimate “Molecular Shuttle” For Delivering Next- Generation Technologies Like TALEN And CRISPR Into The Cell. Its nanoscale size and unique architecture allow it to serve as an ideal “molecular shuttle” for carrying specialized molecules like drugs, DNA, and enzymes across cells’ outer protective membrane. It can even transport proteins which are known to be very sensitive, easily diminished, and do not efficiently cross membranes. MGMR also does NOT cause damage or toxicity to the cell like other delivery methods (i.e. viruses and electricity). It migrates into the cell via a natural transport process called endocytosis and releases its medicine payload using diffusion.
